Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 5.3% | 6.6% | 8.4% | 7.3% | (48.3%) | 10.2% | 8.5% | 9.7% | 14.9% | 13.9% | 13.1% | 14.6% | 8.9% | 33.9% | (3.1%) | 12.6% | 13.0% | 14.0% | (5.4%) | 13.5% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 12.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Prestige Consumer Healthcare Inc. have been 7.9% over the past three years, and 8.1% over the past five years.
As of today, Prestige Consumer Healthcare Inc.'s Return on Equity (ROE) is 12.1%, which is higher than industry median of 6.3%. It indicates that Prestige Consumer Healthcare Inc.'s Return on Equity (ROE) is Good.